Clinical Trials Browser

Colonic Neoplasms × avelumab × Clear all

NCT03854799 2023-10-19

AVANA

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms

NCT03827044 2022-10-07

POLEM

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Microsatellite Instability

NCT03608046 2020-10-22

AVETUXIRI

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms